Applications of Molecular Diagnostics: Solid Tumor Genetics Can Determine Clinical Treatment Protocols
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (3) , 254-257
- https://doi.org/10.1038/modpathol.3880294
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Diagnosis and Classification of Small Round-Cell Tumors of ChildhoodThe American Journal of Pathology, 1999
- CAN p53 HELP SELECT PATIENTS WITH INVASIVE BLADDER CANCER FOR BLADDER PRESERVATION?Journal of Urology, 1999
- SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaNew England Journal of Medicine, 1998
- p53 and treatment of bladder cancerNature, 1997
- Cancer Cell CyclesScience, 1996
- Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complexNature, 1996
- Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Cell, 1996
- Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary TumorsCell, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994